Clinical trials
Phase 2 Glomerulonephritis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 6 |
| Recruiting | 4 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 3 |
| Goldfinch Bio, Inc. | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Novartis Pharmaceuticals | 2 |
| argenx | 2 |
| Alexandria University | 1 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Fernando Fervenza | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glomerulonephritis | 24 |
| Kidney Diseases | 11 |
| Glomerulonephritis, IGA | 8 |
| Nephritis | 6 |
| Proteinuria | 6 |
| Lupus Nephritis | 5 |
| Urologic Diseases | 5 |
| Autoimmune Diseases | 4 |
| Immune System Diseases | 4 |
| Glomerulonephritis, Membranous | 3 |
Trials
Showing 76 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.